Cargando…

Lamin B1 regulates somatic mutations and progression of B-cell malignancies

Somatic hypermutation (SHM) is a pivotal process in adaptive immunity that occurs in the germinal centre and allows B cells to change their primary DNA sequence and diversify their antigen receptors. Here, we report that genome binding of Lamin B1, a component of the nuclear envelope involved in epi...

Descripción completa

Detalles Bibliográficos
Autores principales: Klymenko, T, Bloehdorn, J, Bahlo, J, Robrecht, S, Akylzhanova, G, Cox, K, Estenfelder, S, Wang, J, Edelmann, J, Strefford, J C, Wojdacz, T K, Fischer, K, Hallek, M, Stilgenbauer, S, Cragg, M, Gribben, J, Braun, A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5808072/
https://www.ncbi.nlm.nih.gov/pubmed/28804121
http://dx.doi.org/10.1038/leu.2017.255
_version_ 1783299394325446656
author Klymenko, T
Bloehdorn, J
Bahlo, J
Robrecht, S
Akylzhanova, G
Cox, K
Estenfelder, S
Wang, J
Edelmann, J
Strefford, J C
Wojdacz, T K
Fischer, K
Hallek, M
Stilgenbauer, S
Cragg, M
Gribben, J
Braun, A
author_facet Klymenko, T
Bloehdorn, J
Bahlo, J
Robrecht, S
Akylzhanova, G
Cox, K
Estenfelder, S
Wang, J
Edelmann, J
Strefford, J C
Wojdacz, T K
Fischer, K
Hallek, M
Stilgenbauer, S
Cragg, M
Gribben, J
Braun, A
author_sort Klymenko, T
collection PubMed
description Somatic hypermutation (SHM) is a pivotal process in adaptive immunity that occurs in the germinal centre and allows B cells to change their primary DNA sequence and diversify their antigen receptors. Here, we report that genome binding of Lamin B1, a component of the nuclear envelope involved in epigenetic chromatin regulation, is reduced during B-cell activation and formation of lymphoid germinal centres. Chromatin immunoprecipitation-Seq analysis showed that kappa and heavy variable immunoglobulin domains were released from the Lamin B1 suppressive environment when SHM was induced in B cells. RNA interference-mediated reduction of Lamin B1 resulted in spontaneous SHM as well as kappa-light chain aberrant surface expression. Finally, Lamin B1 expression level correlated with progression-free and overall survival in chronic lymphocytic leukaemia, and was strongly involved in the transformation of follicular lymphoma. In summary, here we report that Lamin B1 is a negative epigenetic regulator of SHM in normal B-cells and a ‘mutational gatekeeper’, suppressing the aberrant mutations that drive lymphoid malignancy.
format Online
Article
Text
id pubmed-5808072
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-58080722018-02-14 Lamin B1 regulates somatic mutations and progression of B-cell malignancies Klymenko, T Bloehdorn, J Bahlo, J Robrecht, S Akylzhanova, G Cox, K Estenfelder, S Wang, J Edelmann, J Strefford, J C Wojdacz, T K Fischer, K Hallek, M Stilgenbauer, S Cragg, M Gribben, J Braun, A Leukemia Original Article Somatic hypermutation (SHM) is a pivotal process in adaptive immunity that occurs in the germinal centre and allows B cells to change their primary DNA sequence and diversify their antigen receptors. Here, we report that genome binding of Lamin B1, a component of the nuclear envelope involved in epigenetic chromatin regulation, is reduced during B-cell activation and formation of lymphoid germinal centres. Chromatin immunoprecipitation-Seq analysis showed that kappa and heavy variable immunoglobulin domains were released from the Lamin B1 suppressive environment when SHM was induced in B cells. RNA interference-mediated reduction of Lamin B1 resulted in spontaneous SHM as well as kappa-light chain aberrant surface expression. Finally, Lamin B1 expression level correlated with progression-free and overall survival in chronic lymphocytic leukaemia, and was strongly involved in the transformation of follicular lymphoma. In summary, here we report that Lamin B1 is a negative epigenetic regulator of SHM in normal B-cells and a ‘mutational gatekeeper’, suppressing the aberrant mutations that drive lymphoid malignancy. Nature Publishing Group 2018-02 2017-09-01 /pmc/articles/PMC5808072/ /pubmed/28804121 http://dx.doi.org/10.1038/leu.2017.255 Text en Copyright © 2018 The Author(s) http://creativecommons.org/licenses/by/4.0/ This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/
spellingShingle Original Article
Klymenko, T
Bloehdorn, J
Bahlo, J
Robrecht, S
Akylzhanova, G
Cox, K
Estenfelder, S
Wang, J
Edelmann, J
Strefford, J C
Wojdacz, T K
Fischer, K
Hallek, M
Stilgenbauer, S
Cragg, M
Gribben, J
Braun, A
Lamin B1 regulates somatic mutations and progression of B-cell malignancies
title Lamin B1 regulates somatic mutations and progression of B-cell malignancies
title_full Lamin B1 regulates somatic mutations and progression of B-cell malignancies
title_fullStr Lamin B1 regulates somatic mutations and progression of B-cell malignancies
title_full_unstemmed Lamin B1 regulates somatic mutations and progression of B-cell malignancies
title_short Lamin B1 regulates somatic mutations and progression of B-cell malignancies
title_sort lamin b1 regulates somatic mutations and progression of b-cell malignancies
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5808072/
https://www.ncbi.nlm.nih.gov/pubmed/28804121
http://dx.doi.org/10.1038/leu.2017.255
work_keys_str_mv AT klymenkot laminb1regulatessomaticmutationsandprogressionofbcellmalignancies
AT bloehdornj laminb1regulatessomaticmutationsandprogressionofbcellmalignancies
AT bahloj laminb1regulatessomaticmutationsandprogressionofbcellmalignancies
AT robrechts laminb1regulatessomaticmutationsandprogressionofbcellmalignancies
AT akylzhanovag laminb1regulatessomaticmutationsandprogressionofbcellmalignancies
AT coxk laminb1regulatessomaticmutationsandprogressionofbcellmalignancies
AT estenfelders laminb1regulatessomaticmutationsandprogressionofbcellmalignancies
AT wangj laminb1regulatessomaticmutationsandprogressionofbcellmalignancies
AT edelmannj laminb1regulatessomaticmutationsandprogressionofbcellmalignancies
AT streffordjc laminb1regulatessomaticmutationsandprogressionofbcellmalignancies
AT wojdacztk laminb1regulatessomaticmutationsandprogressionofbcellmalignancies
AT fischerk laminb1regulatessomaticmutationsandprogressionofbcellmalignancies
AT hallekm laminb1regulatessomaticmutationsandprogressionofbcellmalignancies
AT stilgenbauers laminb1regulatessomaticmutationsandprogressionofbcellmalignancies
AT craggm laminb1regulatessomaticmutationsandprogressionofbcellmalignancies
AT gribbenj laminb1regulatessomaticmutationsandprogressionofbcellmalignancies
AT brauna laminb1regulatessomaticmutationsandprogressionofbcellmalignancies